Pharmaceutical Business review

Zila names new board member

The appointment increases the board to six members, five of whom are non-employee directors. Mr Brooksby is currently CFO of InNexus Biotechnical, a publicly traded drug development company. Previously, Mr Brooksby was CFO of Energy West, a publicly traded energy utility.

Mr Brooksby has earned a bachelor of science degree in accounting and a masters degree in accounting from Brigham Young University.

David Bethune, chairman and CEO of Zila, said: “Wade brings to Zila’s board of directors extensive operating experience gained as a senior executive for organizations of all sizes. His background adds depth to our already talented and diverse board. We welcome Wade and look forward to his guidance as we work toward achieving our long-term strategic goals.”